Skip to main content
. 2021 Dec 28;5(24):5626–5630. doi: 10.1182/bloodadvances.2021005292

Figure 1.

Figure 1.

Interval from last WBRT to CAR T-cell therapy and progression-free survival (PFS). PFS is for patients who were bridged with WBRT. Black line, median time (21 days) from last WBRT to CAR T-cell treatment; green line, median PFS (83 days). (→) Ongoing CR; (↓) relapsed.